Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Uterine cancer
ADR ID BADD_A04475
ADR Hierarchy
21      Reproductive system and breast disorders
21.07      Uterine, pelvic and broad ligament disorders
21.07.02      Uterine neoplasms
21.07.02.003      Uterine cancer
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.12      Reproductive neoplasms female malignant and unspecified
16.12.05      Uterine neoplasms malignant NEC
16.12.05.001      Uterine cancer
Description Tumors or cancer of the UTERUS. [MeSH]
MedDRA Code 10046766
MeSH ID D014594
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer of body of uterus | Cancer of uterine body | Carcino-sarcoma uterus | Carcinoma body of uterus | Carcinoma corpus uteri | Carcinosarcoma uterus | Corpus uteri carcinoma | Malignant neoplasm of body of uterus | Malignant neoplasm of corpus uteri, except isthmus | Malignant neoplasm of isthmus | Malignant neoplasm of other specified sites of body of uterus | Malignant neoplasm of other specified sites of uterine adnexa | Malignant neoplasm of parametrium | Malignant neoplasm of uterus, part unspecified | Uterine cancer | Uterine cancer NOS | Uterine cancer, body | Uterine carcinoma | Uterine adenocarcinoma | Malignant neoplasm of corpus uteri, excl isthmus | Uterine Neoplasms | Neoplasms, Uterus | Neoplasm, Uterus | Uterus Neoplasm | Uterus Neoplasms | Neoplasms, Uterine | Neoplasm, Uterine | Uterine Neoplasm | Cancer of Uterus | Uterus Cancers | Cancer of the Uterus | Uterus Cancer | Cancer, Uterus | Cancers, Uterus | Uterine Cancer | Cancer, Uterine | Cancers, Uterine | Uterine Cancers
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000044%
BADD_D00142Anastrozole0.000318%
BADD_D00195Azathioprine0.000313%
BADD_D00286Bosutinib0.000112%
BADD_D00474Cisplatin0.000168%
BADD_D00511Clozapine0.004891%
BADD_D00535Crizotinib0.000112%
BADD_D00680Dimethyl fumarate0.002400%
BADD_D00821Estradiol0.000062%
BADD_D00858Everolimus0.000306%
BADD_D00978Fulvestrant0.000501%
BADD_D01110Hydroxyurea0.000168%
BADD_D01136Imatinib0.000224%
BADD_D01253Lenalidomide0.002411%
BADD_D01257Letrozole0.000395%
BADD_D01281Levonorgestrel0.002837%
BADD_D01336Macitentan0.000241%
BADD_D01418Methotrexate--
BADD_D01567Nilotinib0.000168%
BADD_D01653Paclitaxel0.000224%
BADD_D01676Paricalcitol0.002943%
BADD_D01687Pazopanib0.000168%
BADD_D01834Prednisone--
BADD_D01903Raloxifene0.000226%
BADD_D01913Ranitidine0.001188%
BADD_D01954Rivaroxaban0.000317%
BADD_D02018Sildenafil0.000107%
BADD_D02100Sunitinib0.000246%
BADD_D02111Tamoxifen0.000595%
BADD_D02112Tamoxifen citrate--
The 1th Page    1 2    Next   Last    Total 2 Pages